BETHLEHEM, Pa., June 13, 2017 -- B. Braun Medical Inc. will highlight its commitment to reducing healthcare-acquired infections when it introduces new products that help reduce interaoperative bacterial contamination of stopcocks at the APIC conference being held June 14-16.
The Anesthesia Disinfection Workstation, which includes the new DOCit™ and HubScrub™ disposable sterilization devices, are designed to help organize the anesthesia work space in an operating room. The DOCit device is intended to disinfect and clean syringe tips and male luer connectors, and the HubScrub device is intended to disinfect and clean needleless connectors and stopcocks.
“In collaboration with SAXA Medical Solutions, LLC, B. Braun is bringing surgical suites the Anesthesia Disinfection Workstation system, which can reduce the incidence of stopcock contamination1,” said Steve Weber, Director of Marketing, IV Systems,
B. Braun. “This workstation is designed to improve intravascular device disinfection in the operating room, which in turn can contribute to the reduction of healthcare-acquired infections.”4
The DOCit device for male luers is designed to organize and protect syringe tips from contamination. The DOCit device scrubs and disinfects male luer tip connectors and needleless syringes with 70 percent isopropyl alcohol (IPA).2 Disinfection of the male luer tip occurs after two 360-degree rotations within 10 seconds.3
The HubScrub device is a female luer disinfector and cleaner with 70 percent IPA. Disinfection of the needleless connector is achieved after two 360-degree rotations within 10 seconds.3 The HubScrub device can provide a microbial barrier to contamination for up to 7 days if not removed.2
“The peri-, intra- and post-operative venues have a tremendous opportunity and responsibility to safeguard vascular access for patients,” says Anthony J. Colantonio, M.D., DABA, Chief Medical and Innovations Officer, SAXA Medical Solutions. “The scientific evidence demonstrates an association between bacterial contamination of vascular access devices in the anesthesia work area and healthcare acquired infections.4
“The Anesthesia Disinfection Workstation and DOCit and HubScrub devices deliver unique functionality with practicality to facilitate a long-needed change in the culture of our infection control practices, as they are designed to meet the standards of vascular access care and reduce device contamination,” Colantonio said.
APIC attendees can learn more about the Anesthesia Disinfection Workstation and DOCit and HubScrub devices at the B. Braun booth # 545 at the conference at the Oregon Convention Center in Portland.
In addition, B. Braun will sponsor “Improving Intravascular Device Disinfection in Today’s Operating Rooms: Clinical Implications, Methodology and Fidelity Measurement” presented by Randy Loftus, M.D., Associate Professor, Anesthesiology. The presentation will be held 6:30 to 7:45 a.m. on Wednesday, June 14, in Oregon Ballroom 204, at the convention center. Complimentary breakfast will be served from 6 to 6:30 a.m. No registration is required.
The other B. Braun products to be featured at the show include: InVision-Plus CS® IV connector with Neutral Advantage Technology; STEADYCare™ extension set with the Wedge™ catheter stabilizer; Introcan Safety® IV catheter; and Ster-ASSIST™ Sterile peripheral IV catheter insertion kit.
For more information, visit www.BBraunFightDirt.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
SAXA Medical Solutions, LLC is the manufacturer of the DOCit™ and HubScrub™ devices. DOCit and HubScrub are registered trademarks of SAXA Medical Solutions, LLC. B. Braun is a distributor of the Anesthesia Disinfection Workstation, DOCit and HubScrub.
- Loftus, R., et al. Reduction in Intraoperative Bacterial Contamination of Peripheral Intravenous Tubing Through the Use of a Passive Catheter System, Anesthesia-Analgesia, December 2012; Volume 115; Number 6.
- PDS 201501115 data on file with SAXA Medical Solutions.
- T16-037 Rev. 01 data on file with SAXA Medical Solutions.
- Loftus, R., et al. Transmission of Pathogenic Bacterial Organisms in the Anesthesia Work Area, Anesthesiology, S September 2008; Volume 109; Number 3.
Contact: Jason Ford B. Braun Medical Inc. 610.997.4722 [email protected]


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



